Drug giant Merck agreed to buy antibiotics maker Cubist Pharmaceuticals for $8.4 billion, part of its push to focus on the acute care market.
WSJ.com: Europe Home, Wall Street Journal: World: Home Europe
Mon, 12/08/2014 - 5:27am
Drug giant Merck agreed to buy antibiotics maker Cubist Pharmaceuticals for $8.4 billion, part of its push to focus on the acute care market.